The development of multidrug resistance in cancer cells: the potential of ABC transporter-targeted therapy to overcome inefficiency of treatment

Adamska, A., Falasca, M. 2018. ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward? World Journal of Gastroenterology, 24(29): 3222–3238.
Google Scholar DOI: https://doi.org/10.3748/wjg.v24.i29.3222

Begicevic, R.R., Falasca, M. 2017. ABC transporters in cancer stem cells: Beyond chemoresistance. International Journal of Molecular Sciences, 18(11): 2362.
Google Scholar DOI: https://doi.org/10.3390/ijms18112362

Bloise, E., Ortiga-Calvalho, T.M., Reis, F.M., Lye, S.J., Gibb, W., Matthews, S.G. 2016. ATP-binding cassette transporters in reproduction: A new frontier. Human Reproduction Update, 22(2): 164–181.
Google Scholar DOI: https://doi.org/10.1093/humupd/dmv049

Choi, Y., Yu, A. 2014. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. Current Pharmaceutical Design, 20(5), 793–807.
Google Scholar DOI: https://doi.org/10.2174/138161282005140214165212

Dantzic, D., Noel, P., Merien, F., Liu, D-X., Lu, J., Han, H., McKeage, M.J., Li, Y. 2018. The effects of synthetically modified natural compounds on ABC transporters. Pharmaceutics, 10(3): 127.
Google Scholar DOI: https://doi.org/10.3390/pharmaceutics10030127

Fultang, N., Illendula, A., Lin, J., Pandey, M.K., Klase, Z., Peethambaran, B. 2020. ROR1 regulates chemoresistance in breast cancer via modulation of drug efflux pump ABCB1. Scientific Reports, 10(1): 1821.
Google Scholar DOI: https://doi.org/10.1038/s41598-020-58864-0

Goldstein, L.J. 1995. Clinical reversal of drug resistance. Current Problems in Cancer, 19(2): 65–124.
Google Scholar DOI: https://doi.org/10.1016/S0147-0272(07)80004-3

Gomez-Zepeda, D., Taghi, M., Scherrmann, J-M., Decleves, X., Menet, M-C. 2020. ABC transporters at the blood-brain interfaces, their study models, and drug delivery implications in gliomas. Pharmaceutics, 12(1): 20.
Google Scholar DOI: https://doi.org/10.3390/pharmaceutics12010020

Janmaat, V.T., Steyerberg, E.W., van der Gast, A., Mathijssen, R., Bruno, M.J., Peppelenbosch, M.P., Kuipers, E.J., Spaander, M. 2017. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. Cochrane Database of Systematic Reviews, 11(11): CD004063.
Google Scholar DOI: https://doi.org/10.1002/14651858.CD004063.pub4

Kim, K., Khang, D. 2020. Past, present, and future of anticancer nanomedicine. International Journal of Nanomedicine, 15: 5719–5743.
Google Scholar DOI: https://doi.org/10.2147/IJN.S254774

Koh, J., Itahana, Y., Mendenhall, I.H., Low, D., Soh, E.X.Y., Guo, A.K., Chionh, Y.T., Wang, L-F., Itahana, K. 2019. ABCB1 protects bat cells from DNA damage induced by genotoxic compounds. Nature Communications, 10: 2820.
Google Scholar DOI: https://doi.org/10.1038/s41467-019-10495-4

Trock, B.J., Leonessa, F., Clarke, R. 1997. Multidrug resistance in breast cancer: A meta-analysis of MDR1/Gp170 expression and its possible functional significance. Journal of the National Cancer Institute, 89(13): 917–931.
Google Scholar DOI: https://doi.org/10.1093/jnci/89.13.917

Wu, S., Fu, L. 2018. Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells. Molecular Cancer, 7(1): 25.
Google Scholar DOI: https://doi.org/10.1186/s12943-018-0775-3